ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
78,42
-0,60
(-0,76%)
Geschlossen 09 Juni 10:00PM

Abbott Laboratories (ABL) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
78,42
( -0,76% )
Gebot
78,26
Fragen
78,60
Volumen
4.678
78,40 Tagesbereich 79,48
69,62 52-Wochen-Bereich 119,80
Marktkapitalisierung
Handelsende
79,02
Handelsbeginn
78,86
Letzte Trade
27
@
78.48
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
12.775.289 €
Ausgegebene Aktien
1.741.813.154
Dividendenrendite (LTM)
2,44 (2,99%)
Kurs-Gewinn-Verhältnis
25,51
Gewinn pro Aktie (EPS)
3,57
Erlöse (LTM)
45,13B
Nettogewinn (LTM)
6,28B

Über Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceutic... Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois. Mehr anzeigen

Sektor
Healthcare
Branche
Medical Equipment & Supplies
Website
Hauptsitz
Abbott Park, United States
Gegründet
1888
Abbott Laboratories is listed in the Healthcare sector of the Tradegate (DE) with ticker ABL. The last closing price for Abbott Laboratories was 79,02 €. Over the last year, Abbott Laboratories shares have traded in a share price range of 69,62 € to 119,80 €.

Abbott Laboratories currently has 1.741.813.154 shares in issue. The market capitalisation of Abbott Laboratories is 136,59 € billion. Abbott Laboratories has a price to earnings ratio (PE ratio) of 25.51.

ABL Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
15.247.16042634673.1879.8473.14748276.56824982DE
45.928.1655172413872.579.8469.62721873.93130694DE
12-15.58-16.57446808519497.1369.62624877.95963677DE
26-28.36-26.5592807642106.78110.6669.62472085.04809567DE
52-38.34-32.8365878726116.76119.869.62304491.55990348DE
156-17.35-18.116320350895.77134.7469.62210098.44678508DE
260-12.78-14.013157894791.2134.7469.62153499.75874307DE

ABL - Frequently Asked Questions (FAQ)

What is the current Abbott Laboratories share price?
The current share price of Abbott Laboratories is 78,42 €
How many Abbott Laboratories shares are in issue?
Abbott Laboratories has 1.741.813.154 shares in issue
What is the market cap of Abbott Laboratories?
The market capitalisation of Abbott Laboratories is EUR 136,59B
What is the 1 year trading range for Abbott Laboratories share price?
Abbott Laboratories has traded in the range of 69,62 € to 119,80 € during the past year
What is the PE ratio of Abbott Laboratories?
The price to earnings ratio of Abbott Laboratories is 25,51
What is the cash to sales ratio of Abbott Laboratories?
The cash to sales ratio of Abbott Laboratories is 3,51
What is the registered address of Abbott Laboratories?
The registered address for Abbott Laboratories is 100 Abbott Park Road, Abbott Park, Illinois, 60064-6400
What is the Abbott Laboratories website address?
The website address for Abbott Laboratories is www.abbott.com
Which industry sector does Abbott Laboratories operate in?
Abbott Laboratories operates in the Medical Equipment & Supplies sector

ABL Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen